RxDoctor Payments Data

Shilpa Reddy, MD

Dermatology · Albuquerque, NMNPI 1639218639

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 33.5% of the total.

$3,227in general payments, 2019–2025

Across 170 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$669
  • Novartis$305
  • Lilly USA, LLC$177
  • Amgen$125
  • Johnson & Johnson$123
  • plus $747 from 15 others

What the payments were for

  • Food & beverage$3,227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,227 in reported general payments places this provider in the 80th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico

Medicare billing

Part B allowed, 2024
$398,489
Medicare patients
1,044
Services billed
6,687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene31$5,081
Fluorouracil50$3,223
Azelaic Acid30$2,576
Fluocinonide79$2,203
Clobetasol Propionate51$1,730
Metronidazole37$1,600
Doxycycline Hyclate54$1,295
Clindamycin Phosphate37$1,212
Tacrolimus14$1,077
Ketoconazole68$982
Hydrocortisone134$819
Triamcinolone Acetonide139$819
Nystatin64$690
Betamethasone Dipropionate16$514
Mupirocin51$512

Paid to pharmacies, not to this prescriber.

Other dermatology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →